Louisiana: Dupixent (dupilumab) litigati… | DrugsMonitor.com

Dupixent (dupilumab) litigation in Louisiana (LA): MDL-linked practice notes, filing-deadline context, confidential review—not legal advice.

dupilumab, atopic dermatitis, asthma, ocular surface disease, keratitis, vision injury, Louisiana